市場調査報告書：バイオインフォマティクス　現状と市場予測

Abstract

Bioinformatics is a set of enabling technologies responsible for the annotation, storage, analysis and search/retrieval of nucleic acid sequence, protein sequence and structural information. This includes integration of the information on the sequences and structures of nucleic acids and proteins into databases such as EMBL, as well as methods to access, search, model and analyze this information.

This BCC study examines the current status of the worldwide bioinformatics industry and assesses its growth potential over a six-year period to 2010. Of particular interest is the value added by bioinformatics in the process of drug discovery and development. Also examined are various technologies and patenting trends in the industry. In addition, market potential for emerging bioinformatics applications such as gene therapy, molecular medicine, etc. is assessed.

Primary focus is on the application of bioinformatics to the process of drug discovery and development, the major user of the technology. Worldwide activity in this sector was considered for this report.

INTRODUCTION
EXECUTIVE SUMMARY
- Summary Table: WORLDWIDE VALUE OF BIOINFORMATICS MARKET, THROUGH 2010 ($ MILLIONS)
- Summary Figure: WORLDWIDE VALUE OF BIOINFORMATICS MARKET, 2002-2010 ($ MILLIONS)
OVERVIEW
- Figure 1 DEFINING BIOINFORMATICS
  - BIOINFORMATICS IN BIOTECHNOLOGY
  - CONCEPTS IN THE INDUSTRY
- Table 1 WORLDWIDE MARKET FOR BIOINFORMATICS, BY FIELDS OF STUDY, THROUGH 2010 ($ MILLIONS)
- Table 2 WORLDWIDE MARKET FOR GENOMICS, THROUGH 2010 ($ MILLIONS)
- Table 3 WORLDWIDE MARKET FOR PROTEOMICS, THROUGH 2010 ($ MILLIONS)
- Table 4 WORLDWIDE MARKET FOR PHARMACOGENOMICS, THROUGH 2010 ($ MILLIONS)
- Table 5 WORLDWIDE MARKET FOR CHEMINFORMATICS, THROUGH 2010 ($ MILLIONS)
  - TECHNOLOGY DEVELOPMENT
  - HISTORY AND DEVELOPMENT OF INDUSTRY
- Figure 2 KEY DEVELOPMENTS IN BIOINFORMATICS TECHNOLOGIES, 1990-2010
  - DESCRIPTION OF MAJOR TECHNOLOGIES/APPLICATIONS
    - BIOINFORMATICS IN DRUG DISCOVERY AND DEVELOPMENT
- Table 6 R&D EXPENDITURE ON DRUG DISCOVERY AND DEVELOPMENT, THROUGH 2005 ($ MILLIONS)
- Table 7 LIFE CYCLE OF A DRUG
  - FORESEEABLE FUTURE DEVELOPMENTS
    - EMERGENCE OF NEW TECHNOLOGIES
      - Image Informatics
      - Microarray Data Production
      - In Silico Biology
        
        Protein Folding Computation
      - Translational Research
      - Influence of Genomics Versus Proteomics
      - Metabolomics and the Central Dogma of Molecular Biology
- Figure 3 CENTRAL DOGMA OF MOLECULAR BIOLOGY AND BIOINFORMATICS
- Figure 4 FUTURE TRENDS IN BIOINFORMATICS
MARKETS BY PRODUCT
- Figure 5 KEY DYNAMICS IN BIOINFORMATICS INDUSTRY
  - TOTAL MARKET SIZE
- Table 8 WORLDWIDE BIOINFORMATICS MARKET, BY PRODUCT, THROUGH 2010 ($ MILLIONS)
  - PRODUCT CATEGORIES
    - CONTENT
      - Description and Market Size by Database
- Figure 6 CATEGORIES OF BIOINFORMATICS DATABASES AND THEIR CONTENT
- Table 9 WORLDWIDE BIOINFORMATICS CONTENT MARKET BY DATABASE TYPE, THROUGH 2010 ($ MILLIONS)
- Table 10 WORLDWIDE GENERALIZED DATABASE MARKET BY TYPE OF CONTENT, THROUGH 2010 ($ MILLIONS)
- Table 11 SAMPLE LIST OF MAJOR GENERALIZED BIOINFORMATCS DATABASES
- Table 12 WORLDWIDE SPECIALIZED DATABASE MARKET BY TYPE OF CONTENT, THROUGH 2010 ($ MILLIONS)
- Table 13 SAMPLE LIST OF MAJOR SPECIALIZED BIOINFORMATICS DATABASES
- Table 14 WORLDWIDE BIOINFORMATICS CONTENT MARKET BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)
- Table 15 WORLDWIDE BIOINFORMATICS MARKET BY GENOMICS CONTENT, THROUGH 2010 ($ MILLIONS)
- Table 16 WORLDWIDE BIOINFORMATICS MARKET BY PROTEOMICS CONTENT, THROUGH 2010 ($ MILLIONS)
- Table 17 WORLDWIDE BIOINFORMATICS MARKET BY PHARMACOGENOMICS CONTENT, THROUGH 2010 ($ MILLIONS)
- Table 18 WORLDWIDE BIOINFORMATICS MARKET BY CHEMINFORMATICS CONTENT, THROUGH 2010 ($ MILLIONS)
- Table 19 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN BIOINFORMATICS, BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)
- Table 20 WORLDWIDE ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN GENOMICS AND PROTEOMICS, THROUGH 2010 ($ MILLIONS)
- Table 21 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN GENOMICS AND PROTEOMICS BY SOFTWARE CATEGORY, THROUGH 2010 ($ MILLIONS)
- Table 22 LIST OF SAMPLE SEQUENCE ANALYSIS SOFTWARE
- Table 23 LIST OF SAMPLE STRUCTURE PREDICTION SOFTWARE/PROGRAMS
- Table 24 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN PHARMACOGENOMICS, THROUGH 2010 ($ MILLIONS)
- Table 25 LIST OF SAMPLE SNP ANALYSIS SOFTWARE/PROGRAMS
- Table 26 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN CHEMINFORMATICS, THROUGH 2010 ($ MILLIONS)
- Table 27 WORLDWIDE BIOINFORMATICS IT INFRASTRUCTURE AND SERVICES MARKET BY TYPE OF EQUIPMENT, THROUGH 2010 ($ MILLIONS)
- Table 28 COMPONENTS OF A CLUSTER
- Table 29 WORLDWIDE MARKET FOR IT INFRASTRUCTURE AND SERVICES EMPLOYED IN BIOINFORMATICS, BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)
- Table 30 KEY GROWTH DRIVERS FOR BIOINFORMATICS PRODUCTS
MARKETS BY END-USER
- Table 31 WORLDWIDE MARKET FOR BIOINFORMATICS BY END-USER, THROUGH 2010 ($ MILLIONS)
  - DRUG DISCOVERY AND DEVELOPMENT
    - APPLICATION DESCRIPTION
- Figure 7 VARIOUS PHASES IN DRUG DISCOVERY AND DEVELOPMENT PROCESS
- Table 32 WORLDWIDE MARKET FOR BIOINFORMATICS BY DRUG-DISCOVERY APPLICATION, THROUGH 2010 ($ MILLIONS)
- Table 33 SNAPSHOT OF THE DRUG DEVELOPMENT PROCESS
- Table 34 WORLDWIDE MARKET FOR BIOINFORMATICS BY DRUG DEVELOPMENT APPLICATION, THROUGH 2010 ($ MILLIONS)
- Table 35 NUMBER OF DRUGS WITH PATENTS EXPIRING, GROUPED BY TREATMENT, 2001-2004
- Table 36 PATENT EXPIRATIONS DUE ON BLOCKBUSTER DRUGS, 2004-2008
  - MOLECULAR MEDICINE
    - APPLICATION DESCRIPTION
      - Pharmacogenomics and Personalized Medicine
        
        Advantages
        Disadvantages
      - Gene Testing and Preventive Medicine
        
        Advantages
        Disadvantages
      - Gene Therapy
        
        Gene Therapy (Continued)
        Advantages
        Disadvantages
- Table 37 WORLDWIDE MARKET FOR BIOINFORMATICS BY MOLECULAR MEDICINE APPLICATION, THROUGH 2010 ($ MILLIONS)
  - MICROBIAL GENOME APPLICATIONS
    - APPLICATION DESCRIPTION
- Table 38 SAMPLE APPLICATION PROJECTS OF BIOINFORMATICS TOOLS AND RESOURCES
- Table 39 MICROORGANISMS INVOLVED IN NITRIFICATION, SEQUENCED USING BIOINFORMATICS TOOLS
  - AGRICULTURAL APPLICATIONS
    - APPLICATION DESCRIPTION
      - Application Description (Continued)
- Table 40 LIST OF SAMPLE PLANT GENOME DATABASES
  - COMPARATIVE STUDIES
    - COMPARATIVE STUDIES (CONTINUED)
MARKETS BY REGION
- Table 41 BIOINFORMATICS MARKET BY REGION, THROUGH 2010 ($ MILLIONS)
- Table 42 BIOINFORMATICS MARKET IN THE U.S., THROUGH 2010 ($ MILLIONS)
- Table 43 DEPARTMENT OF ENERGY FUNDING FOR THE MICROBIAL GENOME PROJECT, 1997-2004 ($ MILLIONS)
- Table 44 BIOINFORMATICS MARKET IN EUROPE, THROUGH 2010 ($ MILLIONS)
- Table 45 BIOINFORMATICS MARKET IN ASIA PACIFIC, THROUGH 2010 ($ MILLIONS)
- Table 46 BIOINFORMATICS MARKET IN JAPAN, THROUGH 2010 ($ MILLIONS)
TECHNOLOGY OVERVIEW
- Table 47 MAJOR SOFTWARE LANGUAGES USED IN BIOINFORMATICS SOFTWARE AND THEIR APPLICATION AREAS
  - MODES OF DATA INTEGRATION
- Table 48 MODES OF DATA INTEGRATION EMPLOYED IN BIOINFORMATICS BUSINESSES
- Figure 8 DATA WAREHOUSING APPROACH IN BIOINFORMATICS BUSINESSES
  - KEY DEVELOPMENTS
- Table 49 KEY HISTORICAL DEVELOPMENTS IN BIOINFORMATICS TECHNOLOGIES, 1965-2000
  - PATENT OVERVIEW
    - PATENT TYPES
    - ANALYSIS OF PATENTS BY FIELD OF STUDY
- Table 50 BIOINFORMATICS PATENTS BY FIELD OF STUDY IN 2003 AND 2004
- Figure 9 GENOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)
- Figure 10 PROTEOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)
- Figure 11 PHARMACOGENOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)
- Figure 12 CHEMINFORMATICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)
- Figure 13 COMPARISON OF MAJOR FILERS OF GENOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)
- Figure 14 COMPARISON OF MAJOR FILERS OF PROTEOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)
- Figure 15 COMPARISON OF MAJOR FILERS OF PHARMACOGENOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)
- Figure 16 COMPARISON OF MAJOR FILERS OF CHEMINFORMATICS PATENTS, 2003-2004 (NUMBER OF PATENTS)
- Table 51 BIOINFORMATICS PATENTS BY REGION, 2003 AND 2004
- Figure 17 BIOINFORMATICS PATENTS BY REGION, 2003-2004 (%)
- Figure 18 GENOMICS PATENTS BY REGION, 2003-2004 (%)
- Figure 19 PROTEOMICS PATENTS BY REGION, 2003-2004 (%)
- Figure 20 PHARMACOGENOMICS PATENTS BY REGION, 2003-2004 (%)
- Figure 21 CHEMINFORMATICS PATENTS BY REGION, 2003-2004 (%)
  - ABSTRACTS OF RELEVANT PATENTS BY FIELD OF STUDY
    - GENOMICS
      - Synthetic Tag Genes
      - Complexity Management of Genomic DNA by Locus Specific Amplication
      - Method for Analyzing a Nucleic Acid
    - PROTEOMICS
      - Proteomic Analysis
      - Methods of Obtaining Isoform Specific Expression in Mammalian Cells
    - PHARMACOGENOMICS
      - Human Polypeptides Encoded by Polynucleotides and Methods of Their Use
    - CHEMINFORMATICS
      - Method and System for Extracting Data From Surface Array Deposited Features
      - Molecular Nephrotoxicology Modeling
      - System and Method for Chemical Process Scale-Up and Preliminary Design and Analysis
      - Methods and Systems for Annotating Biomolecular Sequences
INDUSTRY STRUCTURE AND COMPETITIVE ANALYSIS
- Figure 22 BIOINFORMATICS INDUSTRY GROWTH CURVE
- Figure 23 SKILL SET REQUIREMENTS FOR BIOINFORMATICS ANALYSTS
- Figure 24 DATA ANALYSIS AS A CHALLENGE FOR BIOINFORMATICS RESEARCHERS
- Figure 25 BIOINFORMATICS INDUSTRY-VALUE CHAIN
- Figure 26 COMPARISON OF THE COST AND VALUE ADDED BY DIFFERENT BUSINESS MODELS EMPLOYED IN BIOINFORMATICS BUSINESSES
  - PRESENT AND FUTURE TRENDS IN THE BIOINFORMATICS INDUSTRY
    - OUTSOURCING TRENDS IN INDUSTRY
  - INDUSTRY STRUCTURE
    - THREATS OF NEW ENTRANTS
    - BARGAINING POWER OF BUYERS
    - BARGAINING POWER OF SUPPLIERS
    - INTER-INDUSTRY COMPETITION
    - THREATS OF SUBSTITUTES
- Figure 27 PORTERS FIVE FORCES MODEL APPLIED TO THE BIOINFORMATICS INDUSTRY
- Table 52 MAJOR MERGERS, ACQUISITIONS AND ALLIANCES IN THE BIOINFORMATICS INDUSTRY
- Table 52 (CONTINUED)
- Table 53 R&D SPENDING IN THE NATIONAL INSTITUTE OF HEALTH (NIH)
  - PROFILES OF COMPANIES
    - ACCELRYS
    - AFFYMETRIX
    - AGILENT TECHNOLOGIES
    - AMERSHAM BIOSCIENCES
    - CELERA
    - COMPUGEN
    - CURAGEN
    - GENE LOGIC
    - GEOSPIZA
    - IBM LIFE SCIENCES
    - INCYTE
    - LION BIOSCIENCE AG
    - SILICON GRAPHICS
    - TRIPOS
      - Tripos (Continued)
APPENDICES
LIST OF TABLES
Summary Table:
Table 1 WORLDWIDE MARKET FOR BIOINFORMATICS, BY FIELDS OF STUDY, THROUGH 2010 ($ MILLIONS)
Table 2 WORLDWIDE MARKET FOR GENOMICS, THROUGH 2010 ($ MILLIONS)
Table 3 WORLDWIDE MARKET FOR PROTEOMICS, THROUGH 2010 ($ MILLIONS)
Table 4 WORLDWIDE MARKET FOR PHARMACOGENOMICS, THROUGH 2010 ($ MILLIONS)
Table 5 WORLDWIDE MARKET FOR CHEMINFORMATICS, THROUGH 2010 ($ MILLIONS)
Table 6 R&D EXPENDITURE ON DRUG DISCOVERY AND DEVELOPMENT, THROUGH 2005 ($ MILLIONS)
Table 7 LIFE CYCLE OF A DRUG
Table 8 WORLDWIDE BIOINFORMATICS MARKET, BY PRODUCT, THROUGH 2010 ($ MILLIONS)
Table 9 WORLDWIDE BIOINFORMATICS CONTENT MARKET BY DATABASE TYPE, THROUGH 2010 ($ MILLIONS)
Table 10 WORLDWIDE GENERALIZED DATABASE MARKET BY TYPE OF CONTENT, THROUGH 2010 ($ MILLIONS)
Table 11 SAMPLE LIST OF MAJOR GENERALIZED BIOINFORMATCS DATABASES
Table 12 WORLDWIDE SPECIALIZED DATABASE MARKET BY TYPE OF CONTENT, THROUGH 2010 ($ MILLIONS)
Table 13 SAMPLE LIST OF MAJOR SPECIALIZED BIOINFORMATICS DATABASES
Table 14 WORLDWIDE BIOINFORMATICS CONTENT MARKET BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)
Table 15 WORLDWIDE BIOINFORMATICS MARKET BY GENOMICS CONTENT, THROUGH 2010 ($ MILLIONS)
Table 16 WORLDWIDE BIOINFORMATICS MARKET BY PROTEOMICS CONTENT, THROUGH 2010 ($ MILLIONS)
Table 17 WORLDWIDE BIOINFORMATICS MARKET BY PHARMACOGENOMICS CONTENT, THROUGH 2010 ($ MILLIONS)
Table 18 WORLDWIDE BIOINFORMATICS MARKET BY CHEMINFORMATICS CONTENT, THROUGH 2010 ($ MILLIONS)
Table 19 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN BIOINFORMATICS, BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)
Table 20 WORLDWIDE ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN GENOMICS AND PROTEOMICS, THROUGH 2010 ($ MILLIONS)
Table 21 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN GENOMICS AND PROTEOMICS BY SOFTWARE CATEGORY, THROUGH 2010 ($ MILLIONS)
Table 22 LIST OF SAMPLE SEQUENCE ANALYSIS SOFTWARE
Table 23 LIST OF SAMPLE STRUCTURE PREDICTION SOFTWARE/PROGRAMS
Table 24 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN PHARMACOGENOMICS, THROUGH 2010 ($ MILLIONS)
Table 25 LIST OF SAMPLE SNP ANALYSIS SOFTWARE/PROGRAMS
Table 26 WORLDWIDE MARKET FOR ANALYSIS SOFTWARE AND SERVICES EMPLOYED IN CHEMINFORMATICS, THROUGH 2010 ($ MILLIONS)
Table 27 WORLDWIDE BIOINFORMATICS IT INFRASTRUCTURE AND SERVICES MARKET BY TYPE OF EQUIPMENT, THROUGH 2010 ($ MILLIONS)
Table 28 COMPONENTS OF A CLUSTER
Table 29 WORLDWIDE MARKET FOR IT INFRASTRUCTURE AND SERVICES EMPLOYED IN BIOINFORMATICS, BY FIELD OF STUDY, THROUGH 2010 ($ MILLIONS)
Table 30 KEY GROWTH DRIVERS FOR BIOINFORMATICS PRODUCTS
Table 31 WORLDWIDE MARKET FOR BIOINFORMATICS BY END-USER, THROUGH 2010 ($ MILLIONS)
Table 32 WORLDWIDE MARKET FOR BIOINFORMATICS BY DRUG-DISCOVERY APPLICATION, THROUGH 2010 ($ MILLIONS)
Table 33 SNAPSHOT OF THE DRUG DEVELOPMENT PROCESS
Table 34 WORLDWIDE MARKET FOR BIOINFORMATICS BY DRUG DEVELOPMENT APPLICATION, THROUGH 2010 ($ MILLIONS)
Table 35 NUMBER OF DRUGS WITH PATENTS EXPIRING, GROUPED BY TREATMENT, 2001-2004
Table 36 PATENT EXPIRATIONS DUE ON BLOCKBUSTER DRUGS, 2004-2008
Table 37 WORLDWIDE MARKET FOR BIOINFORMATICS BY MOLECULAR MEDICINE APPLICATION, THROUGH 2010 ($ MILLIONS)
Table 38 SAMPLE APPLICATION PROJECTS OF BIOINFORMATICS TOOLS AND RESOURCES
Table 39 MICROORGANISMS INVOLVED IN NITRIFICATION, SEQUENCED USING BIOINFORMATICS TOOLS
Table 40 LIST OF SAMPLE PLANT GENOME DATABASES
Table 41 BIOINFORMATICS MARKET BY REGION, THROUGH 2010 ($ MILLIONS)
Table 42 BIOINFORMATICS MARKET IN THE U.S., THROUGH 2010 ($ MILLIONS)
Table 43 DEPARTMENT OF ENERGY FUNDING FOR THE MICROBIAL GENOME PROJECT, 1997-2004 ($ MILLIONS)
Table 44 BIOINFORMATICS MARKET IN EUROPE, THROUGH 2010 ($ MILLIONS)
Table 45 BIOINFORMATICS MARKET IN ASIA PACIFIC, THROUGH 2010 ($ MILLIONS)
Table 46 BIOINFORMATICS MARKET IN JAPAN, THROUGH 2010 ($ MILLIONS)
Table 47 MAJOR SOFTWARE LANGUAGES USED IN BIOINFORMATICS SOFTWARE AND THEIR APPLICATION AREAS
Table 48 MODES OF DATA INTEGRATION EMPLOYED IN BIOINFORMATICS BUSINESSES
Table 49 KEY HISTORICAL DEVELOPMENTS IN BIOINFORMATICS TECHNOLOGIES, 1965-2000
Table 50 BIOINFORMATICS PATENTS BY FIELD OF STUDY IN 2003 AND 2004
Table 51 BIOINFORMATICS PATENTS BY REGION, 2003 AND 2004
Table 52 MAJOR MERGERS, ACQUISITIONS AND ALLIANCES IN THE BIOINFORMATICS INDUSTRY
Table 53 R&D SPENDING IN THE NATIONAL INSTITUTE OF HEALTH (NIH)
LIST OF FIGURES
Summary Figure:
Figure 1 DEFINING BIOINFORMATICS
Figure 2 KEY DEVELOPMENTS IN BIOINFORMATICS TECHNOLOGIES, 1990-2010
Figure 3 CENTRAL DOGMA OF MOLECULAR BIOLOGY AND BIOINFORMATICS
Figure 4 FUTURE TRENDS IN BIOINFORMATICS
Figure 5 KEY DYNAMICS IN BIOINFORMATICS INDUSTRY
Figure 6 CATEGORIES OF BIOINFORMATICS DATABASES AND THEIR CONTENT
Figure 7 VARIOUS PHASES IN DRUG DISCOVERY AND DEVELOPMENT PROCESS
Figure 8 DATA WAREHOUSING APPROACH IN BIOINFORMATICS BUSINESSES
Figure 9 GENOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)
Figure 10 PROTEOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)
Figure 11 PHARMACOGENOMICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)
Figure 12 CHEMINFORMATICS PATENTS IN 2003-2004 (NUMBER OF PATENTS)
Figure 13 COMPARISON OF MAJOR FILERS OF GENOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)
Figure 14 COMPARISON OF MAJOR FILERS OF PROTEOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)
Figure 15 COMPARISON OF MAJOR FILERS OF PHARMACOGENOMICS PATENTS, 2003-2004 (NUMBER OF PATENTS)
Figure 16 COMPARISON OF MAJOR FILERS OF CHEMINFORMATICS PATENTS, 2003-2004 (NUMBER OF PATENTS)
Figure 17 BIOINFORMATICS PATENTS BY REGION, 2003-2004 (%)
Figure 18 GENOMICS PATENTS BY REGION, 2003-2004 (%)
Figure 19 PROTEOMICS PATENTS BY REGION, 2003-2004 (%)
Figure 20 PHARMACOGENOMICS PATENTS BY REGION, 2003-2004 (%)
Figure 21 CHEMINFORMATICS PATENTS BY REGION, 2003-2004 (%)
Figure 22 BIOINFORMATICS INDUSTRY GROWTH CURVE
Figure 23 SKILL SET REQUIREMENTS FOR BIOINFORMATICS ANALYSTS
Figure 24 DATA ANALYSIS AS A CHALLENGE FOR BIOINFORMATICS RESEARCHERS
Figure 25 BIOINFORMATICS INDUSTRY-VALUE CHAIN
Figure 26 COMPARISON OF THE COST AND VALUE ADDED BY DIFFERENT BUSINESS MODELS EMPLOYED IN BIOINFORMATICS BUSINESSES
Figure 27 PORTERS FIVE FORCES MODEL APPLIED TO THE BIOINFORMATICS INDUSTRY

バイオインフォマティクス：技術の現状と市場予測

Bioinformatics Business: Technical Status and Market Prospects

Abstract

Table of Contents